<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="547">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04497402</url>
  </required_header>
  <id_info>
    <org_study_id>SAPIENZAGENDERCOVID</org_study_id>
    <nct_id>NCT04497402</nct_id>
  </id_info>
  <brief_title>Sex-Informed Data in the COVID-19 Pandemic.</brief_title>
  <acronym>G-COV</acronym>
  <official_title>Sex-Informed Data in the COVID-19 Pandemic.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sex and gender matter to health equity, especially in a pandemic. Sex (a biological
      attribute) and gender (a social construct) may influence an individual's susceptibility,
      vulnerability and exposure to infectious disease. In previous coronavirus epidemics (SARS and
      MERS), male sex was associated with worse outcomes. Both immune and the hemostatic response
      display ample sexual dimorphism.

      The primary aim of the study is to determine whether sex differences in biomarkers of
      platelet and immune function, gut microbiome, clinical characteristics, therapy, clinical
      cost sensitive outcomes (i.e. in-hospital transition of care, case severity, and mortality
      due to COVID-19) exist in patients affected by COVID-19.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Sex differences in platelet and immune function and COVID19 severity</measure>
    <time_frame>3 months</time_frame>
    <description>Sex differences in biomarkers of platelet and immune function correlate with severity of disease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut microbiome and COVID19 severity</measure>
    <time_frame>3 months</time_frame>
    <description>Differences in the gut microbiome correlate with severity of disease</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>female COVID19 patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>male COVID19 patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>female matched COVID19-free patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>male matched COVID19-free patients</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, plasma, blood cell pellets and faeces
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with laboratory confirmed SARS-Cov-2 infection (positive for real-time
        reverse-transcriptase polymerase-chain reaction assay for pharyngeal swab specimens) of any
        severity (from asymptomatic to severe manifestations).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with laboratory confirmed SARS-Cov-2 infection of any severity.

        Exclusion Criteria:

          -  Pregnancy.

          -  Younger than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>We will apply the gender framework as defined by the Canadian Institutes for Health Research (CIHR) which includes 4 gender domains: Gender Identity; Gender Roles; Gender Relations; and Institutionalized Gender (https://cihr-irsc.gc.ca/e/50836.html). Such factors include occupation, employment, marital status, number of children, and household responsibilities.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefania Basili, MD</last_name>
    <phone>0649972018</phone>
    <email>stefania.basili@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sapienza University of Rome - Policlinico Umberto I Roma</name>
      <address>
        <city>Rome</city>
        <zip>00166</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Stefania Basili, MD</last_name>
      <phone>+390649972018</phone>
      <email>stefania.basili@uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Stefania Basili, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucia Stefanini, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valeria Raparelli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guido Antonelli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefano Corradini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Cangemi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudio Mastroianni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcella Visentini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Ciardi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 31, 2020</study_first_submitted>
  <study_first_submitted_qc>July 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>August 10, 2020</last_update_submitted>
  <last_update_submitted_qc>August 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Stefania Basili</investigator_full_name>
    <investigator_title>Full Professor of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>sex</keyword>
  <keyword>gender</keyword>
  <keyword>thrombosis</keyword>
  <keyword>immunity</keyword>
  <keyword>gut microbiota</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

